Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials (Q37642390)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 January 2014
edit
Language Label Description Also known as
English
Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials
scientific article published on 14 January 2014

    Statements

    Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit